Teleflex (NYSE:TFX) Sets New 52-Week Low - Should You Sell?

Teleflex Incorporated (NYSE:TFX - Get Free Report) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $117.24 and last traded at $117.55, with a volume of 496921 shares trading hands. The stock had previously closed at $121.11.

Analyst Ratings Changes

A number of research firms have commented on TFX. Morgan Stanley reduced their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Wells Fargo & Company lowered their price objective on Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, May 2nd. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Finally, Royal Bank Of Canada reduced their target price on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a report on Friday, May 2nd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $164.63.

Teleflex Trading Up 0.3%

The company has a 50 day simple moving average of $125.67 and a two-hundred day simple moving average of $150.62. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28. The company has a market cap of $5.22 billion, a PE ratio of 37.23, a PEG ratio of 1.84 and a beta of 1.10.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The business's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.21 earnings per share. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend was Tuesday, May 20th. Teleflex's dividend payout ratio (DPR) is currently 42.90%.

Hedge Funds Weigh In On Teleflex

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vontobel Holding Ltd. boosted its position in shares of Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock valued at $248,000 after acquiring an additional 250 shares in the last quarter. Asset Management One Co. Ltd. lifted its stake in Teleflex by 15.6% during the fourth quarter. Asset Management One Co. Ltd. now owns 19,233 shares of the medical technology company's stock worth $3,453,000 after purchasing an additional 2,589 shares during the period. CX Institutional acquired a new stake in Teleflex during the first quarter valued at approximately $105,000. Raymond James Financial Inc. acquired a new stake in Teleflex during the fourth quarter valued at approximately $10,342,000. Finally, IFP Advisors Inc grew its stake in shares of Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after purchasing an additional 217 shares during the period. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.